CG Oncology Q4 Earnings Report: What Investors Need to Know

CG Oncology (NASDAQ:CGON) announced its Q4 earnings on Friday, February 27, 2026 at 08:30 AM.

Here's a breakdown of the earnings report.

Earnings

CG Oncology beat estimated earnings by 13.56%, reporting an EPS of $-0.51 versus an estimate of $-0.59.

Revenue was up $1.87 million from the same period last year.

Overview of Past Earnings

Last quarter the company missed on EPS by $0.01 which was followed by a 8.61% increase in the share price the next day.

Here's a look at CG Oncology's past performance:

Quarter	Q3 2025	Q2 2025	Q1 2025	Q4 2024
EPS Estimate	-0.56	-0.46	-0.28	-0.39
EPS Actual	-0.57	-0.54	-0.45	-0.46
Revenue Estimate	175K	197K	144K	51K
Revenue Actual	1.67M	0	52K	456K

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for CG Oncology visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.